Huifang Shan

Discovery of a PROTAC targeting ALK with in vivo activity

Guoyi Yan, Xin-Xin Zhong, Yue Lin et al. · European Journal of Medicinal Chemistry · 2021 · 51 citations · Full text

Pharmacy, Medicinal Chemistry, Molecular Biology +9

Discovery of a novel covalent CDK4/6 inhibitor based on palbociclib scaffold

Huifang Shan, Xinyu Ma, Guoyi Yan et al. · European Journal of Medicinal Chemistry · 2021 · 22 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Discovery of 4-phenyl-2H-benzo[b][1,4]oxazin-3(4H)-one derivatives as potent and orally active PI3K/mTOR dual inhibitors

Guoyi Yan, Chunlan Pu, Suke Lan et al. · European Journal of Medicinal Chemistry · 2019 · 18 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Severe cutaneous adverse reactions due to antibiotics therapy: a pharmacovigilance analysis of FDA adverse event reporting system events

Lu Zhou, Jing Yang, Min Xiao et al. · Expert Opinion on Drug Safety · 2023 · 14 citations

Pharmacy, Dermatology, Pharmacology +17

Fabrication of Cu-doped molybdenum oxide for bifunctional SERS and photothermal conversion

Huifang Shan, Wenjie Ma, Huanhuan Yang et al. · Materials Chemistry and Physics · 2022 · 12 citations

Natural Sciences, Materials Engineering, Materials Science +12